생화학분자생물학회입니다.
Genome editing of immune cells using the CRISPR/Cas system
작성자
관리자작성일자
2020-12-21조회수
237Name: Chan Hyuk Kim ( Kimchanhyuk@kaist.ac.kr ) | ||
2016-present | Assistant Professor, Department of Biological Sciences, Korea Advanced Institute of Science and Technology | |
2012-2016 | Principal Investigator, Department of Biology, California Institute for Biomedical Research, USA | |
2009-2012 | Postdoctoral research fellow, Scripps Research, USA | |
2004-2008 | Ph.D., Department of Chemistry, Seoul National University |
Genome editing of immune cells using the CRISPR/Cas system
The ability to read, write, and edit genomic information in living organisms can have a profound impact on research, health, economic, and environmental issues. The CRISPR/Cas system, recently discovered as an adaptive immune system in prokaryotes, has revolutionized the ease and throughput of genome editing in mammalian cells and has proved itself indispensable to the engineering of immune cells and identification of novel immune mechanisms. In this review, we summarize the CRISPR/Cas9 system alongside the history of its discovery and optimization. We then focus on engineering T cells and other types of immune cells with emphasis on therapeutic applications. Lastly, we describe the different modifications of Cas9 and their recent applications in the genome-wide screening of immune cells.
BMB Rep 2020 Dec 11;5226. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33298251/